EMEA (Europe, Middle East and Africa) Neisseria meningitidis Infections Drug Market Report 2017

January 2018 | 111 pages | ID: E2E04AF56B3EN
QYResearch

Abstracts

In this report, the EMEA Neisseria meningitidis Infections Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Neisseria meningitidis Infections Drug for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Neisseria meningitidis Infections Drug market competition by top manufacturers/players, with Neisseria meningitidis Infections Drug sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Beijing Minhai Biotechnology Co Ltd
• Biological E Ltd
• China National Pharmaceutical Group Corp
• GlaxoSmithKline Plc
• Griffith University
• ImmunoBiology Ltd
• JN-International Medical Corp
• MGB Biopharma Ltd
• Panacea Biotec Ltd
• Pfizer Inc
• Sanofi Pasteur SA
• Serum Institute of India Ltd
• Wellstat Vaccines LLC

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• MGBBP-3
• NCL-195
• TP-10
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Neisseria meningitidis Infections Drug Market Report 2017

1 NEISSERIA MENINGITIDIS INFECTIONS DRUG OVERVIEW

1.1 Product Overview and Scope of Neisseria meningitidis Infections Drug
1.2 Classification of Neisseria meningitidis Infections Drug
  1.2.1 EMEA Neisseria meningitidis Infections Drug Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Neisseria meningitidis Infections Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 MGBBP-3
  1.2.4 NCL-195
  1.2.5 TP-10
  1.2.6 Others
1.3 EMEA Neisseria meningitidis Infections Drug Market by Application/End Users
  1.3.1 EMEA Neisseria meningitidis Infections Drug Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 EMEA Neisseria meningitidis Infections Drug Market by Region
  1.4.1 EMEA Neisseria meningitidis Infections Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Neisseria meningitidis Infections Drug (2012-2022)
  1.5.1 EMEA Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2022)

2 EMEA NEISSERIA MENINGITIDIS INFECTIONS DRUG COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Neisseria meningitidis Infections Drug Market Competition by Players/Manufacturers
  2.1.1 EMEA Neisseria meningitidis Infections Drug Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Neisseria meningitidis Infections Drug Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Neisseria meningitidis Infections Drug Sale Price by Players (2012-2017)
2.2 EMEA Neisseria meningitidis Infections Drug (Volume and Value) by Type/Product Category
  2.2.1 EMEA Neisseria meningitidis Infections Drug Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Neisseria meningitidis Infections Drug Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Neisseria meningitidis Infections Drug Sale Price by Type (2012-2017)
2.3 EMEA Neisseria meningitidis Infections Drug (Volume) by Application
2.4 EMEA Neisseria meningitidis Infections Drug (Volume and Value) by Region
  2.4.1 EMEA Neisseria meningitidis Infections Drug Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Neisseria meningitidis Infections Drug Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Neisseria meningitidis Infections Drug Sales Price by Region (2012-2017)

3 EUROPE NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  3.1.1 Europe Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
3.2 Europe Neisseria meningitidis Infections Drug Sales and Market Share by Type
3.3 Europe Neisseria meningitidis Infections Drug Sales and Market Share by Application
3.4 Europe Neisseria meningitidis Infections Drug Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Neisseria meningitidis Infections Drug Sales Volume by Countries (2012-2017)
  3.4.2 Europe Neisseria meningitidis Infections Drug Revenue by Countries (2012-2017)
  3.4.3 Germany Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  3.4.4 France Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  3.4.5 UK Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  3.4.6 Russia Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  3.4.7 Italy Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)

4 MIDDLE EAST NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  4.1.1 Middle East Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
4.2 Middle East Neisseria meningitidis Infections Drug Sales and Market Share by Type
4.3 Middle East Neisseria meningitidis Infections Drug Sales and Market Share by Application
4.4 Middle East Neisseria meningitidis Infections Drug Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Neisseria meningitidis Infections Drug Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Neisseria meningitidis Infections Drug Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  4.4.4 Israel Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  4.4.5 UAE Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  4.4.6 Iran Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)

5 AFRICA NEISSERIA MENINGITIDIS INFECTIONS DRUG (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Neisseria meningitidis Infections Drug Sales and Value (2012-2017)
  5.1.1 Africa Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
5.2 Africa Neisseria meningitidis Infections Drug Sales and Market Share by Type
5.3 Africa Neisseria meningitidis Infections Drug Sales and Market Share by Application
5.4 Africa Neisseria meningitidis Infections Drug Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Neisseria meningitidis Infections Drug Sales Volume by Countries (2012-2017)
  5.4.2 Africa Neisseria meningitidis Infections Drug Revenue by Countries (2012-2017)
  5.4.3 South Africa Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Neisseria meningitidis Infections Drug Sales and Growth Rate (2012-2017)

6 EMEA NEISSERIA MENINGITIDIS INFECTIONS DRUG MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Beijing Minhai Biotechnology Co Ltd
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Biological E Ltd
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Biological E Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 China National Pharmaceutical Group Corp
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline Plc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Griffith University
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Griffith University Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 ImmunoBiology Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 JN-International Medical Corp
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 JN-International Medical Corp Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 MGB Biopharma Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Panacea Biotec Ltd
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Pfizer Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Neisseria meningitidis Infections Drug Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Pfizer Inc Neisseria meningitidis Infections Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Sanofi Pasteur SA
6.12 Serum Institute of India Ltd
6.13 Wellstat Vaccines LLC

7 NEISSERIA MENINGITIDIS INFECTIONS DRUG MANUFACTURING COST ANALYSIS

7.1 Neisseria meningitidis Infections Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neisseria meningitidis Infections Drug

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Neisseria meningitidis Infections Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neisseria meningitidis Infections Drug Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST (2017-2022)

11.1 EMEA Neisseria meningitidis Infections Drug Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Neisseria meningitidis Infections Drug Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Neisseria meningitidis Infections Drug Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Neisseria meningitidis Infections Drug Price and Trend Forecast (2017-2022)
11.2 EMEA Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Neisseria meningitidis Infections Drug Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Neisseria meningitidis Infections Drug Sales Forecast by Type (2017-2022)
11.7 EMEA Neisseria meningitidis Infections Drug Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Neisseria meningitidis Infections Drug
Figure EMEA Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Neisseria meningitidis Infections Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure MGBBP-3 Product Picture
Figure NCL-195 Product Picture
Figure TP-10 Product Picture
Figure Others Product Picture
Figure EMEA Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Neisseria meningitidis Infections Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Neisseria meningitidis Infections Drug Market Size (Million USD) by Region (2012-2022)
Figure Europe Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Neisseria meningitidis Infections Drug Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Neisseria meningitidis Infections Drug Revenue (Million USD) Status and Forecast by Countries
Figure Africa Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Neisseria meningitidis Infections Drug Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Neisseria meningitidis Infections Drug Sales Volume and Growth Rate (2012-2022)
Figure EMEA Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Neisseria meningitidis Infections Drug Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales Share by Players (2012-2017)
Figure 2016 Neisseria meningitidis Infections Drug Sales Share by Players
Figure 2017 Neisseria meningitidis Infections Drug Sales Share by Players
Figure EMEA Neisseria meningitidis Infections Drug Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Revenue (Million USD) by Players (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Revenue Share by Players (2012-2017)
Table 2016 EMEA Neisseria meningitidis Infections Drug Revenue Share by Players
Table 2017 EMEA Neisseria meningitidis Infections Drug Revenue Share by Players
Table EMEA Neisseria meningitidis Infections Drug Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Neisseria meningitidis Infections Drug by Type (2012-2017)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share by Type (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Neisseria meningitidis Infections Drug by Type in 2016
Table EMEA Neisseria meningitidis Infections Drug Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Neisseria meningitidis Infections Drug by Application (2012-2017)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share by Application in 2016
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Neisseria meningitidis Infections Drug by Region (2012-2017)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share in 2016
Table EMEA Neisseria meningitidis Infections Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Neisseria meningitidis Infections Drug Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Neisseria meningitidis Infections Drug by Region (2012-2017)
Figure EMEA Neisseria meningitidis Infections Drug Revenue Market Share Regions in 2016
Table EMEA Neisseria meningitidis Infections Drug Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Revenue and Growth Rate (2012-2017)
Table Europe Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2012-2017)
Table Europe Neisseria meningitidis Infections Drug Market Share by Type (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Market Share by Type in 2016
Table Europe Neisseria meningitidis Infections Drug Sales (K Pcs) by Application (2012-2017)
Table Europe Neisseria meningitidis Infections Drug Market Share by Application (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Market Share by Application in 2016
Table Europe Neisseria meningitidis Infections Drug Sales (K Pcs) by Countries (2012-2017)
Table Europe Neisseria meningitidis Infections Drug Sales Market Share by Countries (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Sales Market Share by Countries (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Sales Market Share by Countries in 2016
Table Europe Neisseria meningitidis Infections Drug Revenue (Million USD) by Countries (2012-2017)
Table Europe Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Europe Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2016
Figure Germany Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Market Share by Type (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Market Share by Type (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Sales (K Pcs) by Applications (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Market Share by Applications (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Sales Market Share by Application in 2016
Table Middle East Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Sales Volume Market Share by Countries in 2016
Table Middle East Neisseria meningitidis Infections Drug Revenue (Million USD) by Countries (2012-2017)
Table Middle East Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Middle East Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2016
Figure Saudi Arabia Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Sales (K Pcs) by Type (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share by Type (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share by Type in 2016
Table Africa Neisseria meningitidis Infections Drug Sales (K Pcs) by Application (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share by Application (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Sales Market Share by Countries (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share by Countries (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share by Countries in 2016
Table Africa Neisseria meningitidis Infections Drug Revenue (Million USD) by Countries (2012-2017)
Table Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries (2012-2017)
Figure Africa Neisseria meningitidis Infections Drug Revenue Market Share by Countries in 2016
Figure South Africa Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure Beijing Minhai Biotechnology Co Ltd Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table Biological E Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure Biological E Ltd Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Basic Information List
Table China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure China National Pharmaceutical Group Corp Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Basic Information List
Table GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Plc Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table Griffith University Neisseria meningitidis Infections Drug Basic Information List
Table Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure Griffith University Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Basic Information List
Table ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure ImmunoBiology Ltd Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Basic Information List
Table JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure JN-International Medical Corp Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Basic Information List
Table MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure MGB Biopharma Ltd Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure Panacea Biotec Ltd Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table Pfizer Inc Neisseria meningitidis Infections Drug Basic Information List
Table Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Sales Market Share in EMEA (2012-2017)
Figure Pfizer Inc Neisseria meningitidis Infections Drug Revenue Market Share in EMEA (2012-2017)
Table Sanofi Pasteur SA Neisseria meningitidis Infections Drug Basic Information List
Table Serum Institute of India Ltd Neisseria meningitidis Infections Drug Basic Information List
Table Wellstat Vaccines LLC Neisseria meningitidis Infections Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Neisseria meningitidis Infections Drug
Figure Manufacturing Process Analysis of Neisseria meningitidis Infections Drug
Figure Neisseria meningitidis Infections Drug Industrial Chain Analysis
Table Raw Materials Sources of Neisseria meningitidis Infections Drug Major Manufacturers in 2016
Table Major Buyers of Neisseria meningitidis Infections Drug
Table Distributors/Traders List
Figure EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share Forecast by Region (2017-2022)
Table EMEA Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Region (2017-2022)
Table Europe Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Neisseria meningitidis Infections Drug Sales Market Share Forecast by Countries (2017-2022)
Table Europe Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Neisseria meningitidis Infections Drug Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Neisseria meningitidis Infections Drug Sales Market Share Forecast by Countries (2017-2022)
Table Africa Neisseria meningitidis Infections Drug Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Neisseria meningitidis Infections Drug Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share Forecast by Type (2017-2022)
Table EMEA Neisseria meningitidis Infections Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Neisseria meningitidis Infections Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources